Analysts take a look at Insulet Corporation (NASDAQ:PODD) having this to say.

Insulet Corporation (NASDAQ:PODD) Logo
Investors sentiment increased to 1.12 in 2018 Q4. Its up 0.17, from 0.95 in 2018Q3. It increased, as 28 investors sold Insulet Corporation shares while 63 reduced holdings. 28 funds opened positions while 74 raised stakes. 63.61 million shares or 2.13% more from 62.28 million shares in 2018Q3 were reported.
Credit Suisse Ag holds 48,822 shares. Signaturefd Limited Liability Co invested in 0% or 15 shares. Fred Alger Management reported 1.65M shares stake. Moreno Evelyn V holds 0.98% or 37,250 shares. Amundi Pioneer Asset Mngmt invested in 0.01% or 90,379 shares. 4.88 million were reported by Primecap Co Ca. Great West Life Assurance Can holds 0% or 7,313 shares. Columbus Circle holds 0.73% of its portfolio in Insulet Corporation (NASDAQ:PODD) for 324,787 shares. Bnp Paribas Arbitrage Sa holds 0% or 3,302 shares in its portfolio. Advisory Rech Inc has invested 0.01% in Insulet Corporation (NASDAQ:PODD). California-based Franklin Resource has invested 0% in Insulet Corporation (NASDAQ:PODD). Numerixs Invest holds 0.03% or 1,000 shares in its portfolio. 2.88M are held by Blackrock. State Board Of Administration Of Florida Retirement Sys accumulated 78,407 shares or 0.02% of the stock. Sumitomo Mitsui Asset Mngmt Company Ltd reported 41,889 shares or 0.06% of all its holdings.

Since November 14, 2018, it had 0 insider purchases, and 4 selling transactions for $1.48 million activity. $48,407 worth of stock was sold by Abdel-Malek Aiman on Wednesday, November 14.

Insulet Corporation (NASDAQ:PODD) Ratings Coverage

Among 6 analysts covering Insulet (NASDAQ:PODD), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Insulet had 13 analyst reports since November 28, 2018 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, February 26 by Northland Capital. As per Tuesday, February 26, the company rating was maintained by Oppenheimer. The rating was maintained by Robert W. Baird on Tuesday, February 26 with “Buy”. The firm has “Equal-Weight” rating by Morgan Stanley given on Wednesday, January 2. The stock of Insulet Corporation (NASDAQ:PODD) has “Buy” rating given on Tuesday, February 19 by Canaccord Genuity. Below is a list of Insulet Corporation (NASDAQ:PODD) latest ratings and price target changes.

06/05/2019 Broker: BTIG Research Old Rating: Neutral New Rating: Buy Upgrade
02/05/2019 Broker: BidaskScore Rating: Hold Upgrade
19/04/2019 Broker: BidaskScore Rating: Sell Downgrade
25/03/2019 Broker: Raymond James Rating: Buy Maintain
19/03/2019 Broker: BidaskScore Rating: Buy Upgrade
26/02/2019 Broker: Northland Capital Rating: Buy New Target: $100 Maintain
26/02/2019 Broker: Oppenheimer Rating: Hold New Target: $100 Maintain
26/02/2019 Broker: BTIG Research Rating: Hold Maintain
26/02/2019 Broker: Robert W. Baird Rating: Buy New Target: $118 Maintain
22/02/2019 Broker: BidaskScore Rating: Hold Downgrade

The stock increased 0.88% or $0.9 during the last trading session, reaching $103.46. About 238,484 shares traded. Insulet Corporation (NASDAQ:PODD) has risen 26.95% since May 8, 2018 and is uptrending. It has outperformed by 22.58% the S&P500.

Insulet Corporation, a medical device company, develops, makes, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company has market cap of $6.17 billion. The firm offers Omnipod Insulin Management System , which consists of the OmniPod, an easy-to-use continuous insulin delivery system; and Personal Diabetes Manager, a handheld wireless device. It has a 459.82 P/E ratio. It also customizes the Omnipod System technology platform for the delivery of subcutaneous drugs across various therapeutic areas.

More notable recent Insulet Corporation (NASDAQ:PODD) news were published by: which released: “3 Top Diabetes Stocks to Watch in February – Nasdaq” on February 17, 2019, also with their article: “Insulet Enters Oversold Territory (PODD) – Nasdaq” published on April 17, 2019, published: “Insulet Posts Positive Earnings for the Second Consecutive Quarter – The Motley Fool” on February 26, 2019. More interesting news about Insulet Corporation (NASDAQ:PODD) were released by: and their article: “20 High-Growth Stocks for the Next 20 Years – Motley Fool” published on April 29, 2019 as well as‘s news article titled: “Insulet (PODD) Down 6.9% Since Last Earnings Report: Can It Rebound? – Nasdaq” with publication date: December 01, 2018.

Insulet Corporation (NASDAQ:PODD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.